CCN2 (CTGF) Gene Polymorphism Is a Novel Prognostic Risk Factor for Cardiovascular Outcomes in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|30|4|272-276

ISSN： 0253-5068

Source： Blood Purification, Vol.30, Iss.4, 2010-11, pp. : 272-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylenetetrahydrofolate Reductase Gene Polymorphism, Hyperhomocysteinemia, and Cardiovascular Diseases in Chronic Hemodialysis Patients

By  

Nephron, Vol. 90, Iss. 1, 2001-12 ,pp. : 43-50

Karger

Access to resources Recommend Favorite

Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 4, 2012-01 ,pp. : 247-253

Karger

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease Proven by Transient Elastography in Hemodialysis Patients: Is It a New Risk Factor for Adverse Cardiovascular Events?

By  

Blood Purification, Vol. 37, Iss. 4, 2014-07 ,pp. : 259-265

Karger

Access to resources Recommend Favorite

Vitamin D Receptor Gene Polymorphism and Diabetes mellitus Prevalence in Hemodialysis Patients

By  

Nephron, Vol. 84, Iss. 2, 2000-01 ,pp. : 186-186

Karger

Access to resources Recommend Favorite

Polymorphism of Werner Helicase-Associated Gene in Long-Term Hemodialysis Patients

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 543-543

Karger

Access to resources Recommend Favorite